News/Research on HIV/AIDS Medication Selzentry (Maraviroc, Celsentri)
- Maraviroc Does Not Prevent Immune Reconstitution Syndrome (Video) (March 24, 2013)
From HIVandHepatitis.com
- Maraviroc Plus Atazanavir/Ritonavir in a Nuke-Sparing Regimen in Treatment-Naive Patients (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- High Levels of Maraviroc in Rectal Tissue Fail to Protect Macaques From SIV Transmission Following Rectal Exposure (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- AIDS 2012: Other Treatment Studies (August 1, 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves New Medication for HIV Prevention Study (July 20, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Conference Update From IAS 2011: Medication News (September/October 2011)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Paediatric Antiretroviral Pipeline: Update on Etravirine and Maraviroc (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Selzentry Reduces Liver Stiffness in HIV/HCV-Coinfected Patients (July 21, 2011)
From AIDSmeds.com
- Maraviroc Improves Liver Fibrosis in HIV/Hepatitis C Co-Infected Patients (July 20, 2011)
From aidsmap.com
VIEW ALL ARTICLES
|
Advertisement
|
Email
Glossary
